Found: 3 articles
Article | Edition |
---|---|
Antsiferov M.B., Koteshkova O.M., Antsiferova D.M., Romashkina L.P., Golubeva Yu.V.
Efficacy and safety of the russian GLP-1 receptor agonist Quincenta (semaglutide) in patients with type 2 diabetes mellitus in real clinical practice (QUINPROMIS study. Interim data)
|
№8 / 2024 |
M.B. Antsiferov, O.M. Koteshkova, D.M. Antsiferova, N.A. Demidov
Glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes mellitus: how to choose the right solution
|
№12 / 2023 |
M.B. Antsiferov, O.M. Koteshkova, O.V. Dukhareva, N.A. Demidov, M.S. Novikova
Place of GLP-1 receptor antagonists and SGLT-2 inhibitors in modern therapy of type 2 diabetes mellitus
|
№11-12 / 2022 |